BetalinUK was establish in August of 2020 in Leeds, United Kingdom. In order to initiate research, we’ve been working hard to secure funding to help accelerate our pre-clinical research. BetalinUK has been awarded a Leeds City Region Enterpise Partnership (LEP) greant, #Welcome. This grant has allowed BetalinUK to establish the lab at NEXUS to being work.
In addition to #Welcome, BetalinUK has secured funding from the NHIR’s i4i Connect grants to support pre-clinical activities. Furthermore, through the EU, BetalinUK has been awarded funding from the Horizon 2020 SME scheme, to help with both pre-clinical and clinical activities related to the development of EMP1.
We believe this is only the beginning of our success, with the support of public funding will help strengthen Betalin’s research to start the first-in-man studies, here in the UK.